Physician profile
Lance A Workman
NPI 1477122000
$490.30
in general payments reported to CMS, 2019-2025
11 companies · $346 in 2025
The $346 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $144 · 2025: $346.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $490.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $490.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $88.04 | 2024-2025 | Vaxneuvance, Capvaxive, Gardasil 9 |
| Glaxosmithkline, LLC. | $83.61 | 2024-2025 | Arexvy, Shingrix, Bexsero |
| Radius Health, INC. | $81.59 | 2024-2025 | Tymlos |
| Novo Nordisk INC | $52.04 | 2025 | Wegovy |
| Pfizer INC. | $50.83 | 2024-2025 | |
| Abbvie INC. | $38.94 | 2025 | |
| Viatris Specialty LLC | $23.97 | 2025 | Yupelri |
| Acadia Pharmaceuticals INC | $19.19 | 2024 | Daybue |
| Sanofi Pasteur INC. | $18.74 | 2024 | |
| Amgen INC. | $17.64 | 2025 | Krystexxa |
| Phathom Pharmaceuticals, INC. | $15.71 | 2024 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lance Workman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.